LEADER 00000cam 2200781Ki 4500 001 on1079760145 003 OCoLC 005 20181225051930.1 006 m o d 007 cr cnu---unuuu 008 181220s2009 gw a ob 000 0 eng d 020 9783845212654|q(electronic bk.) 020 3845212659|q(electronic bk.) 020 |z9783832940782 020 |z3832940782 035 (OCoLC)1079760145 037 22573/ctv931vpr|bJSTOR 040 JSTOR|beng|erda|epn|cJSTOR|dOCLCO 043 d------ 049 CKEA 050 4 K3636|b.L39 2009eb 082 04 344.04233|222 084 QX 700|2rvk 084 340|2sdnb 084 PR 2352|2rvk 100 1 Law, Andrew. 245 10 Patents and public health :|blegalising the policy thoughts in the Doha TRIPS Declaration of 14 November 2001 /|cAndrew Law. 250 1. Aufl. 264 1 Baden-Baden :|bNomos ;|bMIPLC, Munich Intellectual Property Law Center,|c2009. 300 1 online resource (291 pages) :|billustrations. 336 text|btxt|2rdacontent 337 computer|bc|2rdamedia 338 online resource|bcr|2rdacarrier 490 1 MIPLC studies ;|vv. 3 500 Originally presented as the author's thesis (doctoral)-- Universität, München, 2008. 504 Includes bibliographical references (pages 251-261). 505 0 Introduction -- Patents and society -- The legalising policy thoughts in the Public Health Declaration -- The circumstances leading up to the Public Health Declaration -- An analysis of the TRIPS agreement -- The Public Health Declaration -- The solution to the paragraph 6 dilemma -- The realisation opportunities afforded by the Public Health Declaration -- Definitive consequences of the Public Health Declaration. 588 0 Print version record. 630 00 Agreement on Trade-Related Aspects of Intellectual Property Rights|d(1994 April 15) 630 07 Agreement on Trade-Related Aspects of Intellectual Property Rights (1994 April 15)|2fast|0(OCoLC)fst01774033 630 07 Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum.|2swd 630 07 Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum|f1994 April 15.|2gnd 650 0 Drugs|xLaw and legislation|zDeveloping countries. 650 0 Public health|zDeveloping countries. 650 0 Intellectual property (International law) 650 0 Drugs|vPatents. 650 7 Drugs.|2fast|0(OCoLC)fst00898761 650 7 Drugs|xLaw and legislation.|2fast|0(OCoLC)fst00898830 650 7 Intellectual property (International law)|2fast |0(OCoLC)fst00975795 650 7 Public health.|2fast|0(OCoLC)fst01082238 650 7 Arzneimittel.|2gnd 650 7 Patentschutz.|2gnd 650 7 Zwangslizenz.|2gnd 650 7 Droger|xjuridik och lagstiftning|zU-länder.|2sao 650 7 Folkhälsa|xjuridik och lagstiftning|zU-länder.|2sao 650 7 Patenträtt.|2sao 650 7 LAW / Commercial / General.|2bisacsh 651 0 Entwicklungsländer|xÜbereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum|xArzneimittel |xPatentschutz|xZwangslizenz. 651 7 Developing countries.|2fast|0(OCoLC)fst01242969 651 7 Entwicklungsländer.|2gnd 655 7 Patents.|2fast|0(OCoLC)fst01423842 776 08 |iPrint version:|aLaw, Andrew.|tPatents and public health. |b1. Aufl.|dBaden-Baden : Nomos ; MIPLC, Munich Intellectual Property Law Center, 2009|z9783832940782 |w(DLC) 2009289374|w(OCoLC)299688110 830 0 MIPLC studies ;|vv. 3. 914 on1079760145 994 92|bCKE
|